OCTAGON CAPITAL ADVISORS LP

PrivateCIK: 1839435
Location

NEW YORK, NY

๐Ÿ“‹ What this filing means

OCTAGON CAPITAL ADVISORS LP filed this quarterly 13Fโ€‘HR report disclosing 41 equity positions with a total reported market value of $718.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

41
Positions
$718.65M
Total AUM (reported)
57.40M
Total Shares

Allocation by class

TOTAL AUM$718.65M41 positions
COM$569.12M79.2%
SPONSORED ADS$57.84M8.0%
COM NEW$43.47M6.0%
SHS$39.35M5.5%
COM PAR $.01$7.74M1.1%
CL A$1.12M0.2%

Portfolio Concentration

Top 347.4%4โ€“1027.2%11โ€“2519.9%Rest5.5%TOP 1074.6%0%100%
Top 3$340.75M47.4%
4โ€“10$195.35M27.2%
11โ€“25$142.97M19.9%
Rest$39.59M5.5%

Top 3 weight

47.4%

Top 10 weight

74.6%

Voting Authority Distribution

Total shares with voting rights: 57.40M

Sole

Full voting authority

57.40M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole41
Shared0
Other0
Dominant voting typeSole ยท 100.0% of voting shares
Institutional Holdings41
Rows:

APELLIS PHARMACEUTICALS INC

SOLE
COM
Shares2.62M
TypeSH
Market value$238.53M
33.19%
Sole
2.62M
Shared
0.00
None
0.00

VERONA PHARMA PLC

SOLE
SPONSORED ADS
Shares2.47M
TypeSH
Market value$52.17M
7.26%
Sole
2.47M
Shared
0.00
None
0.00

CYMABAY THERAPEUTICS INC

SOLE
COM
Shares4.57M
TypeSH
Market value$50.05M
6.96%
Sole
4.57M
Shared
0.00
None
0.00

ARCUS BIOSCIENCES INC

SOLE
COM
Shares1.97M
TypeSH
Market value$39.97M
5.56%
Sole
1.97M
Shared
0.00
None
0.00

ROIVANT SCIENCES LTD

SOLE
SHS
Shares3.90M
TypeSH
Market value$39.35M
5.48%
Sole
3.90M
Shared
0.00
None
0.00

MIRATI THERAPEUTICS INC

SOLE
COM
Shares750K
TypeSH
Market value$27.10M
3.77%
Sole
750K
Shared
0.00
None
0.00

CELLDEX THERAPEUTICS INC NEW

SOLE
COM NEW
Shares759.90K
TypeSH
Market value$25.78M
3.59%
Sole
759.90K
Shared
0.00
None
0.00

VIRIDIAN THERAPEUTICS INC

SOLE
COM
Shares923K
TypeSH
Market value$21.96M
3.06%
Sole
923K
Shared
0.00
None
0.00

BRIDGEBIO PHARMA INC

SOLE
COM
Shares1.22M
TypeSH
Market value$20.97M
2.92%
Sole
1.22M
Shared
0.00
None
0.00

89BIO INC

SOLE
COM
Shares1.07M
TypeSH
Market value$20.22M
2.81%
Sole
1.07M
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares415K
TypeSH
Market value$18.43M
2.56%
Sole
415K
Shared
0.00
None
0.00

VIR BIOTECHNOLOGY INC

SOLE
COM
Shares650.10K
TypeSH
Market value$15.95M
2.22%
Sole
650.10K
Shared
0.00
None
0.00

RENEO PHARMACEUTICALS INC

SOLE
COM
Shares2.37M
TypeSH
Market value$15.54M
2.16%
Sole
2.37M
Shared
0.00
None
0.00

TANDEM DIABETES CARE INC

SOLE
COM NEW
Shares474.93K
TypeSH
Market value$11.65M
1.62%
Sole
474.93K
Shared
0.00
None
0.00

AEROVATE THERAPEUTICS INC

SOLE
COM
Shares621.71K
TypeSH
Market value$10.66M
1.48%
Sole
621.71K
Shared
0.00
None
0.00

ITEOS THERAPEUTICS INC

SOLE
COM
Shares596K
TypeSH
Market value$7.89M
1.10%
Sole
596K
Shared
0.00
None
0.00

DYNE THERAPEUTICS INC

SOLE
COM
Shares692.95K
TypeSH
Market value$7.80M
1.08%
Sole
692.95K
Shared
0.00
None
0.00

INSMED INC

SOLE
COM PAR $.01
Shares367K
TypeSH
Market value$7.74M
1.08%
Sole
367K
Shared
0.00
None
0.00

ALPINE IMMUNE SCIENCES INC

SOLE
COM
Shares750K
TypeSH
Market value$7.71M
1.07%
Sole
750K
Shared
0.00
None
0.00

TRAVERE THERAPEUTICS INC

SOLE
COM
Shares495K
TypeSH
Market value$7.60M
1.06%
Sole
495K
Shared
0.00
None
0.00

GERON CORP

SOLE
COM
Shares2.28M
TypeSH
Market value$7.31M
1.02%
Sole
2.28M
Shared
0.00
None
0.00

XILIO THERAPEUTICS INC

SOLE
COM
Shares2.42M
TypeSH
Market value$6.35M
0.88%
Sole
2.42M
Shared
0.00
None
0.00

AN2 THERAPEUTICS INC

SOLE
COM
Shares720.90K
TypeSH
Market value$6.13M
0.85%
Sole
720.90K
Shared
0.00
None
0.00

JASPER THERAPEUTICS INC

SOLE
COM
Shares4.47M
TypeSH
Market value$6.12M
0.85%
Sole
4.47M
Shared
0.00
None
0.00

VIKING THERAPEUTICS INC

SOLE
COM
Shares375K
TypeSH
Market value$6.08M
0.85%
Sole
375K
Shared
0.00
None
0.00
Page 1 of 2
OCTAGON CAPITAL ADVISORS LP 13F Holdings โ€” 41 Positions | Finecho